Bristol Myers Touts Opdivo Win in Esophageal Cancer, But Yervoy-Opdivo Combo Comes with Caution
Merck's Keytruda/Chemo Combo Therapy Wins EU Backing For Esophageal Cancer
Coherus Shares Are Trading Higher As Toripalimab Shows Survival Benefit In Late-Stage Esophageal Cancer Study
Bristol-Myers' Opdivo-Chemo Combo Associated With Overall Survival Benefit In Esophageal Cancer